Join Weave Bio’s Shannon Mulhern and Mark Hober for lunch and a candid discussion on how AI is changing regulatory work across drug development. Connect with peers, exchange practical perspectives, and explore what this shift means for the teams behind regulatory content.
Event
Philadelphia Lunch & Discussion